However, the role of GPX3 in the leukemogenesis of AML is still elusive and recent studies have been trying to correlate between the pattern of GPX3 mRNA expression level in newly diagnosed AML patients and its effect on clinical and survival outcomes. Here, GPX3 is linked to acute myeloid leukemia.